Orthofix International | OFIX - Ebitda


Orthofix International reported $27.88M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 27.28M 10.21M Jun/2026
Dexcom USD 364.5M 57.7M Mar/2026
EDAP TMS EUR -6.47M 1.54M Mar/2026
Globus Medical USD 279.84M 48.01M Jun/2026
Insulet USD 199.8M 18.1M Jun/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
J&J USD 8.27B 1.08B Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 27.88M 2.77M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Smith & Nephew USD 796M 139M Dec/2025
STAAR Surgical USD 20M 387K Jun/2026
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 6.42M 3.69M Jun/2026
Teleflex USD 75.63M 171.44M Mar/2026
Veracyte USD 43.96M 1.16M Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026